Skip to main content
SpringerLink
Log in

Overview of Metabolic Syndrome

Metabolic Syndrome

  • 630 Accesses

Abstract

The diagnosis of metabolic syndrome is based on the presence of abdominal obesity, increased blood pressure, elevated glucose and triglycerides, and low high-density lipoprotein cholesterol (HDL-C) levels. The prevalence of metabolic syndrome has increased globally mainly due to excessive intake of energy-dense foods and reduced physical activity. Metabolic syndrome increases the risk of developing type 2 diabetes (T2D), cardiovascular diseases, nonalcoholic fatty liver disease (NAFLD), cancer, infertility, dementia, and other diseases. The purpose of this book is to highlight the epidemiology, pathophysiology, clinical features, and treatment of metabolic syndrome. We are hopeful the chapters will provide valuable current insights as well as critical questions to guide future research.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC, Jr., International Diabetes Federation Task Force on E, Prevention, Hational Heart L, Blood I, American Heart A, World Heart F, International Atherosclerosis S, International Association for the Study of O (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644

    Article  CAS  PubMed  Google Scholar 

  • Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabetic medicine: a journal of the British Diabetic Association 23 (5):469–480. doi:10.1111/j.1464-5491.2006.01858.x

    Article  CAS  Google Scholar 

  • Alberti KG, Zimmet P, Shaw J, Group IDFETFC (2005) The metabolic syndrome--a new worldwide definition. Lancet 366 (9491):1059–1062. doi:10.1016/S0140-6736(05)67402-8

    Article  PubMed  Google Scholar 

  • Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabetic medicine: a journal of the British Diabetic Association 15 (7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S

    Article  CAS  Google Scholar 

  • Albrink MJ, Krauss RM, Lindgrem FT, von der Groeben J, Pan S, Wood PD (1980) Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population. Lipids 15 (9):668–676

    Article  CAS  PubMed  Google Scholar 

  • Apovian CM, Aronne L, Rubino D, Still C, Wyatt H, Burns C, Kim D, Dunayevich E, Group C-IS (2013) A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity-related risk factors (COR-II). Obesity 21 (5):935–943. doi:10.1002/oby.20309

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, Kirby A, Sourjina T, Peto R, Collins R, Simes R, Cholesterol Treatment Trialists C (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (9493):1267–1278. doi:10.1016/S0140-6736(05)67394-1

    Article  CAS  PubMed  Google Scholar 

  • Balkau B, Charles MA (1999) Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR). Diabetic medicine: a journal of the British Diabetic Association 16 (5):442–443

    Article  CAS  Google Scholar 

  • Berenson GS, Srinivasan SR, Bao W, Newman WP, 3rd, Tracy RE, Wattigney WA (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. The New England journal of medicine 338 (23):1650–1656. doi:10.1056/NEJM199806043382302

    Article  CAS  PubMed  Google Scholar 

  • Billes SK, Sinnayah P, Cowley MA (2014) Naltrexone/bupropion for obesity: an investigational combination pharmacotherapy for weight loss. Pharmacological research: the official journal of the Italian Pharmacological Society 84:1–11. doi:10.1016/j.phrs.2014.04.004

    Article  CAS  Google Scholar 

  • Bloomgarden ZT (2003) American Association of Clinical Endocrinologists (AACE) consensus conference on the insulin resistance syndrome: 25–26 August 2002, Washington, DC. Diabetes care 26 (4):1297–1303

    Article  PubMed  Google Scholar 

  • Bolinder J, Ljunggren O, Kullberg J, Johansson L, Wilding J, Langkilde AM, Sugg J, Parikh S (2012) Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin. The Journal of clinical endocrinology and metabolism 97 (3):1020–1031. doi:10.1210/jc.2011-2260

    Article  CAS  PubMed  Google Scholar 

  • Borghi C, Santi F (2012) Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence. Patient preference and adherence 6:449–455. doi:10.2147/PPA.S23232

    Article  PubMed Central  PubMed  Google Scholar 

  • Brunner EJ, Marmot MG, Nanchahal K, Shipley MJ, Stansfeld SA, Juneja M, Alberti KG (1997) Social inequality in coronary risk: central obesity and the metabolic syndrome. Evidence from the Whitehall II study. Diabetologia 40 (11):1341–1349. doi:10.1007/s001250050830

    Article  CAS  PubMed  Google Scholar 

  • Chien KL, Lee BC, Hsu HC, Lin HJ, Chen MF, Lee YT (2008) Prevalence, agreement and classification of various metabolic syndrome criteria among ethnic Chinese: a report on the hospital-based health diagnosis of the adult population. Atherosclerosis 196 (2):764–771. doi:10.1016/j.atherosclerosis.2007.01.006

    Article  CAS  PubMed  Google Scholar 

  • Cholesterol Treatment Trialists C, Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380 (9841):581–590. doi:10.1016/S0140-6736(12)60367-5

    Article  Google Scholar 

  • Chrysant SG, Chrysant GS, Chrysant C, Shiraz M (2010) The treatment of cardiovascular disease continuum: focus on prevention and RAS blockade. Current clinical pharmacology 5 (2):89–95

    Article  CAS  PubMed  Google Scholar 

  • Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH, investigators C (2004) Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 364 (9435):685–696. doi:10.1016/S0140-6736(04)16895-5

    Article  CAS  PubMed  Google Scholar 

  • Cook S, Auinger P, Li C, Ford ES (2008) Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999–2002. The Journal of pediatrics 152 (2):165–170. doi:10.1016/j.jpeds.2007.06.004

    Article  PubMed  Google Scholar 

  • Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH (2003) Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Archives of pediatrics & adolescent medicine 157 (8):821–827. doi:10.1001/archpedi.157.8.821

    Article  Google Scholar 

  • Coomans CP, Geerling JJ, van den Berg SA, van Diepen HC, Garcia-Tardon N, Thomas A, Schroder-van der Elst JP, Ouwens DM, Pijl H, Rensen PC, Havekes LM, Guigas B, Romijn JA (2013) The insulin sensitizing effect of topiramate involves KATP channel activation in the central nervous system. British journal of pharmacology 170 (4):908–918. doi:10.1111/bph.12338

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI (2004) The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. The Journal of clinical endocrinology and metabolism 89 (1):108–113. doi:10.1210/jc.2003-031188

    Article  CAS  PubMed  Google Scholar 

  • Dandona P, Aljada A, Bandyopadhyay A (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends in immunology 25 (1):4–7

    Article  CAS  PubMed  Google Scholar 

  • de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N (2004) Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 110 (16):2494–2497. doi:10.1161/01.CIR.0000145117.40114.C7

    Article  PubMed  Google Scholar 

  • DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes care 14 (3):173–194

    Article  CAS  PubMed  Google Scholar 

  • Expert Panel on Detection E, Treatment of High Blood Cholesterol in A (2001) Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama 285 (19):2486–2497

    Article  Google Scholar 

  • Festa A, D’Agostino R, Jr., Howard G, Mykkanen L, Tracy RP, Haffner SM (2000) Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (1):42–47

    Article  CAS  PubMed  Google Scholar 

  • Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama 287 (3):356–359

    Article  PubMed  Google Scholar 

  • Frigolet ME, Torres N, Tovar AR (2013) The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity. The Journal of nutritional biochemistry 24 (12):2003–2015. doi:10.1016/j.jnutbio.2013.07.002

    Article  CAS  PubMed  Google Scholar 

  • Galassi A, Reynolds K, He J (2006) Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. The American journal of medicine 119 (10):812–819. doi:10.1016/j.amjmed.2006.02.031

    Article  CAS  PubMed  Google Scholar 

  • Gill H, Mugo M, Whaley-Connell A, Stump C, Sowers JR (2005) The key role of insulin resistance in the cardiometabolic syndrome. The American journal of the medical sciences 330 (6):290–294

    Article  PubMed  Google Scholar 

  • Grundy SM, Brewer HB, Jr., Cleeman JI, Smith SC, Jr., Lenfant C, American Heart A, National Heart L, Blood I (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (3):433–438. doi:10.1161/01.CIR.0000111245.75752.C6

    Article  PubMed  Google Scholar 

  • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Jr., Spertus JA, Costa F, American Heart A, National Heart L, Blood I (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112 (17):2735–2752. doi:10.1161/CIRCULATIONAHA.105.169404

    Article  PubMed  Google Scholar 

  • Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP (1992) Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41 (6):715–722

    Article  CAS  PubMed  Google Scholar 

  • Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM (2002) Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes care 25 (11):2016–2021

    Article  CAS  PubMed  Google Scholar 

  • Harzallah F, Alberti H, Ben Khalifa F (2006) The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria. Diabetic medicine: a journal of the British Diabetic Association 23 (4):441–444. doi:10.1111/j.1464-5491.2006.01866.x

    Article  CAS  Google Scholar 

  • Ilanne-Parikka P, Eriksson JG, Lindstrom J, Hamalainen H, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Rastas M, Salminen V, Aunola S, Sundvall J, Valle T, Lahtela J, Uusitupa M, Tuomilehto J, Finnish Diabetes Prevention Study G (2004) Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes care 27 (9):2135–2140

    Article  PubMed  Google Scholar 

  • Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM (1989) Influence of body fat distribution on free fatty acid metabolism in obesity. The Journal of clinical investigation 83 (4):1168–1173. doi:10.1172/JCI113997

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S (2007) Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. Journal of the American College of Cardiology 49 (21):2112–2119. doi:10.1016/j.jacc.2007.01.088

    Article  CAS  PubMed  Google Scholar 

  • Jorgensen ME, Bjerregaard P, Gyntelberg F, Borch-Johnsen K, Greenland Population S (2004) Prevalence of the metabolic syndrome among the Inuit in Greenland. A comparison between two proposed definitions. Diabetic medicine: a journal of the British Diabetic Association 21 (11):1237–1242. doi:10.1111/j.1464-5491.2004.01294.x

    Article  CAS  Google Scholar 

  • Kahn R, Buse J, Ferrannini E, Stern M, American Diabetes A, European Association for the Study of D (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes care 28 (9):2289–2304

    Article  PubMed  Google Scholar 

  • Koo BK (2014) Statin for the primary prevention of cardiovascular disease in patients with diabetes mellitus. Diabetes & metabolism journal 38 (1):32–34. doi:10.4093/dmj.2014.38.1.32

    Article  Google Scholar 

  • Laaksonen DE, Niskanen L, Nyyssonen K, Punnonen K, Tuomainen TP, Valkonen VP, Salonen R, Salonen JT (2004) C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 47 (8):1403–1410. doi:10.1007/s00125-004-1472-x

    Article  CAS  PubMed  Google Scholar 

  • Li S, Chen W, Srinivasan SR, Bond MG, Tang R, Urbina EM, Berenson GS (2003) Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. Jama 290 (17):2271–2276. doi:10.1001/jama.290.17.2271

    Article  CAS  PubMed  Google Scholar 

  • Lim S, Meigs JB (2014) Links between ectopic fat and vascular disease in humans. Arteriosclerosis, thrombosis, and vascular biology 34 (9):1820–1826. doi:10.1161/ATVBAHA.114.303035

    Article  CAS  PubMed  Google Scholar 

  • Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won Yoon J, Choi SH, Cho SI, Park KS, Lee HK, Jang HC, Koh KK (2011) Increasing prevalence of metabolic syndrome in Korea: the Korean National Health and Nutrition Examination Survey for 1998–2007. Diabetes care 34 (6):1323–1328. doi:10.2337/dc10-2109

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gonzalez-Sanchez JL, Seclen S, Villena A, Gonzalez-Villalpando C, Williams K, Haffner SM (2006) Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes care 29 (3):685–691

    Article  PubMed  Google Scholar 

  • Lucove JC, Kaufman JS, James SA (2007) Association between adult and childhood socioeconomic status and prevalence of the metabolic syndrome in African Americans: the Pitt County Study. American journal of public health 97 (2):234–236. doi:10.2105/AJPH.2006.087429

    Article  PubMed Central  PubMed  Google Scholar 

  • Marchesini G, Forlani G, Cerrelli F, Manini R, Natale S, Baraldi L, Ermini G, Savorani G, Zocchi D, Melchionda N (2004) WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabetic medicine: a journal of the British Diabetic Association 21 (4):383–387. doi:10.1111/j.1464-5491.2004.01115.x

    Article  CAS  Google Scholar 

  • Mattsson N, Ronnemaa T, Juonala M, Viikari JS, Raitakari OT (2007) The prevalence of the metabolic syndrome in young adults. The Cardiovascular Risk in Young Finns Study. Journal of internal medicine 261 (2):159–169. doi:10.1111/j.1365-2796.2006.01752.x

    Article  CAS  PubMed  Google Scholar 

  • Mozumdar A, Liguori G (2011) Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999–2006. Diabetes care 34 (1):216–219. doi:10.2337/dc10-0879

    Article  PubMed Central  PubMed  Google Scholar 

  • Nestel P, Lyu R, Low LP, Sheu WH, Nitiyanant W, Saito I, Tan CE (2007) Metabolic syndrome: recent prevalence in East and Southeast Asian populations. Asia Pacific journal of clinical nutrition 16 (2):362–367

    PubMed  Google Scholar 

  • Onat A, Can G, Hergenc G, Yazici M, Karabulut A, Albayrak S (2007) Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation. International journal of obesity 31 (7):1119–1125. doi:10.1038/sj.ijo.0803552

    Article  CAS  PubMed  Google Scholar 

  • Onat A, Hergenc G (2011) Low-grade inflammation, and dysfunction of high-density lipoprotein and its apolipoproteins as a major driver of cardiometabolic risk. Metabolism: clinical and experimental 60 (4):499–512. doi:10.1016/j.metabol.2010.04.018

    Article  CAS  Google Scholar 

  • Onat A, Ozhan H, Erbilen E, Albayrak S, Kucukdurmaz Z, Can G, Keles I, Hergenc G (2009) Independent prediction of metabolic syndrome by plasma fibrinogen in men, and predictors of elevated levels. International journal of cardiology 135 (2):211–217. doi:10.1016/j.ijcard.2008.03.054

    Article  PubMed  Google Scholar 

  • Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I, Yazici M, Keles I (2006) Serum uric acid is a determinant of metabolic syndrome in a population-based study. American journal of hypertension 19 (10):1055–1062. doi:10.1016/j.amjhyper.2006.02.014

    Article  CAS  PubMed  Google Scholar 

  • Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S, Diabetes Prevention Program Research G (2005) The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Annals of internal medicine 142 (8):611–619

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Park MJ, Yun KE, Lee GE, Cho HJ, Park HS (2007) A cross-sectional study of socioeconomic status and the metabolic syndrome in Korean adults. Annals of epidemiology 17 (4):320–326. doi:10.1016/j.annepidem.2006.10.007

    Article  PubMed  Google Scholar 

  • Petersen KF, Shulman GI (2006) Etiology of insulin resistance. The American journal of medicine 119 (5 Suppl 1):S10-16. doi:10.1016/j.amjmed.2006.01.009

    Article  PubMed Central  PubMed  Google Scholar 

  • Raitakari OT, Juonala M, Kahonen M, Taittonen L, Laitinen T, Maki-Torkko N, Jarvisalo MJ, Uhari M, Jokinen E, Ronnemaa T, Akerblom HK, Viikari JS (2003) Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. Jama 290 (17):2277–2283. doi:10.1001/jama.290.17.2277

    Article  CAS  PubMed  Google Scholar 

  • Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (12):1595–1607

    Article  CAS  PubMed  Google Scholar 

  • Rubin D, Claas S, Pfeuffer M, Nothnagel M, Foelsch UR, Schrezenmeir J (2008) s-ICAM-1 and s-VCAM-1 in healthy men are strongly associated with traits of the metabolic syndrome, becoming evident in the postprandial response to a lipid-rich meal. Lipids in health and disease 7:32. doi:10.1186/1476-511X-7-32

    Article  PubMed Central  PubMed  Google Scholar 

  • Ruotolo G, Howard BV (2002) Dyslipidemia of the metabolic syndrome. Current cardiology reports 4 (6):494–500

    Article  PubMed  Google Scholar 

  • Sarafidis PA, Nilsson PM (2006) The metabolic syndrome: a glance at its history. Journal of hypertension 24 (4):621–626. doi:10.1097/01.hjh.0000217840.26971.b6

    Article  CAS  PubMed  Google Scholar 

  • Silventoinen K, Pankow J, Jousilahti P, Hu G, Tuomilehto J (2005) Educational inequalities in the metabolic syndrome and coronary heart disease among middle-aged men and women. International journal of epidemiology 34 (2):327–334. doi:10.1093/ije/dyi007

    Article  PubMed  Google Scholar 

  • Smith SM, Meyer M, Trinkley KE (2013) Phentermine/topiramate for the treatment of obesity. The Annals of pharmacotherapy 47 (3):340–349. doi:10.1345/aph.1R501

    Article  PubMed  Google Scholar 

  • Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, Bays H, Shanahan WR, Behavioral M, Lorcaserin for O, Obesity Management Study G (2010) Multicenter, placebo-controlled trial of lorcaserin for weight management. The New England journal of medicine 363 (3):245–256. doi:10.1056/NEJMoa0909809

    Article  CAS  PubMed  Google Scholar 

  • Sun SS, Liang R, Huang TT, Daniels SR, Arslanian S, Liu K, Grave GD, Siervogel RM (2008) Childhood obesity predicts adult metabolic syndrome: the Fels Longitudinal Study. The Journal of pediatrics 152 (2):191–200. doi:10.1016/j.jpeds.2007.07.055

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Vilsboll T, Christensen M, Junker AE, Knop FK, Gluud LL (2012) Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials. Bmj 344:d7771. doi:10.1136/bmj.d7771

    Article  PubMed Central  PubMed  Google Scholar 

  • Wamala SP, Lynch J, Horsten M, Mittleman MA, Schenck-Gustafsson K, Orth-Gomer K (1999) Education and the metabolic syndrome in women. Diabetes care 22 (12):1999–2003

    Article  CAS  PubMed  Google Scholar 

  • Watanabe S, Tagawa T, Yamakawa K, Shimabukuro M, Ueda S (2005) Inhibition of the renin-angiotensin system prevents free fatty acid-induced acute endothelial dysfunction in humans. Arteriosclerosis, thrombosis, and vascular biology 25 (11):2376–2380. doi:10.1161/01.ATV.0000187465.55507.85

    Article  CAS  PubMed  Google Scholar 

  • Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S (2004) Obesity and the metabolic syndrome in children and adolescents. The New England journal of medicine 350 (23):2362–2374. doi:10.1056/NEJMoa031049

    Article  CAS  PubMed  Google Scholar 

  • Weng X, Liu Y, Ma J, Wang W, Yang G, Caballero B (2007) An urban–rural comparison of the prevalence of the metabolic syndrome in Eastern China. Public health nutrition 10 (2):131–136. doi:10.1017/S1368980007226023

    Article  PubMed  Google Scholar 

  • Zabetian A, Hadaegh F, Azizi F (2007) Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes research and clinical practice 77 (2):251–257. doi:10.1016/j.diabres.2006.12.001

    Article  PubMed  Google Scholar 

  • Zreikat HH, Harpe SE, Slattum PW, Mays DP, Essah PA, Cheang KI (2014) Effect of Renin-Angiotensin system inhibition on cardiovascular events in older hypertensive patients with metabolic syndrome. Metabolism: clinical and experimental 63 (3):392–399. doi:10.1016/j.metabol.2013.11.006

    Article  CAS  Google Scholar 

Download references

Acknowledgment

Supported by American Diabetes Association grant #7-13-BS-004 and National Institutes of Health grants R01-NS084965 and P01-DK049210.

Author information

Authors and Affiliations

  1. Perelman School of Medicine, Division of Endocrinology, Diabetes and Metabolism, and the Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania, Philadelphia, PA, 19104, USA

    Rexford S. Ahima

Authors
  1. Rexford S. Ahima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rexford S. Ahima .

Editor information

Editors and Affiliations

  1. Perelman School of Medicine, University of Pennsylvania, Pennsylania, Pennsylvania, USA

    Rexford S. Ahima

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this entry

Cite this entry

Ahima, R.S. (2015). Overview of Metabolic Syndrome. In: Ahima, R. (eds) Metabolic Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-319-12125-3_1-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-12125-3_1-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Online ISBN: 978-3-319-12125-3

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Overview of Metabolic Syndrome
    Published:
    01 August 2023

    DOI: https://doi.org/10.1007/978-3-319-12125-3_1-2

  2. Original

    Overview of Metabolic Syndrome
    Published:
    26 June 2015

    DOI: https://doi.org/10.1007/978-3-319-12125-3_1-1

Search

Navigation